Compare Five Below Inc (FIVE) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Five Below Inc vs Merck & Co., Inc. — how do they compare? Five Below Inc trades at $199.63 (market cap $10.67B), while Merck & Co., Inc. trades at $128.43 (market cap $305.29B). The key difference: Merck & Co., Inc. is far larger — about 28.6× Five Below Inc's market cap, and Merck & Co., Inc. pays a 2.75% dividend while Five Below Inc pays none. Which is the better fit depends on your goals.
| FIVE | MRK | |
|---|---|---|
Market Cap | $10.67B | $305.29B |
Sector | Consumer Staples | Health |
52-Week High | $247.71 | $129.52 |
52-Week Low | $131.94 | $77.60 |
Enterprise Value | $11.56B | $348.71B |
Dividend Yield | — | 2.75% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Five Below (FIVE) trades at $200.59, up 3.87% today, with a bullish technical signal despite mixed moving averages. The company shows strong revenue growth, rising from $2.8B in 2022 to $3.88B in 2025, and has consistently beaten earnings expectations in recent quarters. Positive sentiment is driven by store expansion and digital marketing initiatives, with 60% of analysts rating it a Buy.
The outlook is favorable with a consensus price target of $252.09, implying 26% upside, supported by robust growth projections. Risks include competitive pressures and execution challenges in expansion. Net cash flow improved to $152M in 2025, but profit margins have fluctuated, requiring monitoring of cost management.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Five Below Inc
Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics
Read more on FIVE →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
